Neumora Therapeutics, Inc. (NMRA)
2.075
-0.12
(-5.25%)
USD |
NASDAQ |
Dec 09, 16:00
2.08
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Price to Book Value: 2.623 for Dec. 9, 2025
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| TransMedics Group, Inc. | 12.97 |
| CAMP4 Therapeutics Corp. | 3.676 |
| Puma Biotechnology, Inc. | 2.413 |
| Coherus Oncology, Inc. | 1.776 |
| Ventyx Biosciences, Inc. | 3.173 |
Price to Book Value Related Metrics
| Price | 2.075 |
| Earnings Yield | -70.52% |
| Market Cap | 346.71M |